Ann Farrell

Ann Farrell

UNVERIFIED PROFILE

Are you Ann Farrell?   Register this Author

Register author
Ann Farrell

Ann Farrell

Publications by authors named "Ann Farrell"

Are you Ann Farrell?   Register this Author

100Publications

2362Reads

23Profile Views

Association between short and long sleep durations and cardiovascular outcomes: a systematic review and meta-analysis.

Eur Heart J Acute Cardiovasc Care 2019 Dec 5;8(8):762-770. Epub 2017 Dec 5.

Department of Cardiovascular Diseases, Icahn School of Medicine at Mount Sinai St' Luke, Mount Sinai Heart, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2048872617741733DOI Listing
December 2019

Temperament, Bullying, and Dating Aggression: Longitudinal Associations for Adolescents in a Romantic Relationship.

Evol Psychol 2019 Apr-Jun;17(2):1474704919847450

1 Counselling Psychology, Faculty of Education, University of Ottawa, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1474704919847450DOI Listing
December 2019

FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and Sézary Syndrome.

Clin Cancer Res 2019 Dec 31;25(24):7275-7280. Epub 2019 Jul 31.

Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-2030DOI Listing
December 2019

FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia.

Clin Cancer Res 2019 Oct 7;25(20):6021-6025. Epub 2019 May 7.

Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-0365DOI Listing
October 2019

Overview of Oncology and Hematology Drug Approvals at US Food and Drug Administration Between 2008 and 2016.

J Natl Cancer Inst 2019 May;111(5):449-458

Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy130DOI Listing
May 2019

FDA Approval Summary: Brentuximab Vedotin in First-Line Treatment of Peripheral T-Cell Lymphoma.

Oncologist 2019 May 26;24(5):e180-e187. Epub 2019 Mar 26.

Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0098DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516120PMC
May 2019

FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease.

Clin Cancer Res 2019 01 25;25(2):473-477. Epub 2018 Sep 25.

Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-2337DOI Listing
January 2019

FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B-Cell Acute Lymphoblastic Leukemia.

Oncologist 2018 11 17;23(11):1366-1371. Epub 2018 Jul 17.

Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0179DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291336PMC
November 2018

Quantitative Relationship Between AUEC of Absolute Neutrophil Count and Duration of Severe Neutropenia for G-CSF in Breast Cancer Patients.

Clin Pharmacol Ther 2018 10 2;104(4):742-748. Epub 2018 Feb 2.

Division of Pharmacometrics, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cpt.991
Publisher Site
http://dx.doi.org/10.1002/cpt.991DOI Listing
October 2018

FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia.

Oncologist 2018 09 12;23(9):1103-1108. Epub 2018 Apr 12.

Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0604DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192608PMC
September 2018

First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis.

Eur Urol 2018 09 13;74(3):309-321. Epub 2018 Apr 13.

Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Division of Urology, Department of Surgery, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2018.03.036DOI Listing
September 2018

Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naïve Prostate Cancer: A Systematic Review and Network Meta-analysis.

Eur Urol 2018 06 14;73(6):834-844. Epub 2017 Oct 14.

Division of Urology, Department of Surgery, University of Toronto, Toronto, ON, Canada; Department of Urology and Center for Outcomes Research, Houston Methodist Hospital, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.10.002DOI Listing
June 2018

Dermatologic manifestations of solid organ transplantation-associated graft-versus-host disease: A systematic review.

J Am Acad Dermatol 2018 Jun 27;78(6):1097-1101.e1. Epub 2017 Dec 27.

Department of Dermatology, Mayo Clinic, Rochester, Minnesota; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2017.12.050DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167008PMC
June 2018

FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma.

Oncologist 2018 06 7;23(6):734-739. Epub 2018 Feb 7.

Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0440DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067941PMC
June 2018

A Benefit-Risk Analysis Approach to Capture Regulatory Decision-Making: Multiple Myeloma.

Clin Pharmacol Ther 2018 Jan 20;103(1):67-76. Epub 2017 Nov 20.

U.S. Food and Drug Administration, Center for Drug Evaluation and Research, National Cancer Institute, Silver Spring, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt.871DOI Listing
January 2018

Partial Nephrectomy versus Thermal Ablation for Clinical Stage T1 Renal Masses: Systematic Review and Meta-Analysis of More than 3,900 Patients.

J Vasc Interv Radiol 2018 Jan;29(1):18-29

Department of Urology, University of Texas Health, San Antonio, Texas; Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78229-3900. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2017.08.013DOI Listing
January 2018

Potentially Modifiable Risk Factors for Long-Term Cognitive Impairment After Critical Illness: A Systematic Review.

Mayo Clin Proc 2018 01;93(1):68-82

Multidisciplinary Epidemiology and Translational Research in Intensive Care (METRIC), Emergency and Perioperative Medicine, Mayo Clinic, Rochester, MN; Department of Neurology, Mayo Clinic, Rochester, MN. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2017.11.005DOI Listing
January 2018

Effects of Different Models of Dialysis Care on Patient-Important Outcomes: A Systematic Review and Meta-Analysis.

Popul Health Manag 2017 12 23;20(6):495-505. Epub 2017 Mar 23.

1 Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery , Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/pop.2016.0157DOI Listing
December 2017

U.S. Food and Drug Administration approval summary: Eltrombopag for the treatment of pediatric patients with chronic immune (idiopathic) thrombocytopenia.

Pediatr Blood Cancer 2017 Dec 19;64(12). Epub 2017 Jun 19.

Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26657DOI Listing
December 2017

Commentary on Heath et al.

Clin Trials 2017 12 2;14(6):572-574. Epub 2017 Aug 2.

3 Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1740774517723308DOI Listing
December 2017

Flat Epithelial Atypia on Core Biopsy and Upgrade to Cancer: a Systematic Review and Meta-Analysis.

Ann Surg Oncol 2017 Nov 22;24(12):3549-3558. Epub 2017 Aug 22.

Department of Surgery, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-017-6059-0DOI Listing
November 2017

Flexibility and innovation in the FDA's novel regulatory approval strategies for hematologic drugs.

Blood 2017 09 3;130(11):1285-1289. Epub 2017 Aug 3.

Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-04-742726DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600139PMC
September 2017

Hysteroscopic Morcellation Versus Resection for the Treatment of Uterine Cavitary Lesions: A Systematic Review and Meta-analysis.

J Minim Invasive Gynecol 2016 Sep-Oct;23(6):867-77. Epub 2016 May 7.

Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmig.2016.04.013DOI Listing
July 2017

FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma.

Oncologist 2017 05 24;22(5):585-591. Epub 2017 Apr 24.

Office of Hematology and Oncology Products and Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/lookup/doi/10.1634/th
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2017-0004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423515PMC
May 2017

Cold agglutinin disease complicated by acrocyanosis and necrosis.

Ann Hematol 2017 Mar 3;96(3):509-510. Epub 2017 Jan 3.

Monash Haematology, Monash Health, Level 4, 246 Clayton Road, Clayton, 3168, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2905-6DOI Listing
March 2017

An appraisal of published usability evaluations of electronic health records via systematic review.

J Am Med Inform Assoc 2017 01 23;24(1):218-226. Epub 2016 Apr 23.

Multidisciplinary Epidemiology and Translational Research in Critical Care, Emergency and Perioperative Medicine (METRIC-PM) Group, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://jamia.oxfordjournals.org/content/jaminfo/24/1/218.ful
Web Search
http://dx.doi.org/10.1093/jamia/ocw046DOI Listing
January 2017

Minimal Residual Disease as a Potential Surrogate End Point-Lingering Questions.

JAMA Oncol 2017 Jan;3(1):18-20

Office of Hematology and Oncology Products, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.3112DOI Listing
January 2017

Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials-Response.

Clin Cancer Res 2016 11;22(22):5618

Office of Hematology and Oncology Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-2140DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895452PMC
November 2016

Carbapenem-resistant Enterobacteriaceae and endoscopy: An evolving threat.

Am J Infect Control 2016 09 11;44(9):1032-6. Epub 2016 May 11.

William S. Middleton Memorial Veterans Affairs Hospital, Madison, WI; Division of Infectious Diseases, Department of Medicine, University of Wisconsin Medical School, Madison, WI; Department of Infection Control, University of Wisconsin Hospital and Clinics, Madison, WI.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01966553163000
Publisher Site
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069197PMC
http://dx.doi.org/10.1016/j.ajic.2016.03.029DOI Listing
September 2016

Detection of Carotid Atherosclerotic Plaque Neovascularization Using Contrast Enhanced Ultrasound: A Systematic Review and Meta-Analysis of Diagnostic Accuracy Studies.

J Am Soc Echocardiogr 2016 06 30;29(6):491-502. Epub 2016 Mar 30.

Division of Cardiovascular Diseases, Mayo Clinic Cardiovascular Ultrasound Imaging and Hemodynamic Laboratory, Mayo Clinic, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.echo.2016.02.012DOI Listing
June 2016

Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials: Symptomatic Adverse Events, Physical Function, and Disease-Related Symptoms.

Clin Cancer Res 2016 Apr 12;22(7):1553-8. Epub 2016 Jan 12.

Office of Hematology and Oncology Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-2035DOI Listing
April 2016

Relations between adolescent ratings of Rothbart's temperament questionnaire and the HEXACO personality inventory.

J Pers Assess 2015 7;97(2):163-71. Epub 2014 Aug 7.

a Department of Child and Youth Studies , Brock University , St. Catharines , Ontario , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00223891.2014.940961DOI Listing
February 2016

Regulatory perspective on minimal residual disease flow cytometry testing in multiple myeloma.

Cytometry B Clin Cytom 2016 Jan 25;90(1):73-80. Epub 2015 Jul 25.

Center for Drug Evaluation and Research (CDER) and Center for Devices and Radiologic Health (CDRH), Food and Drug Administration (FDA).

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cyto.b.21268
Publisher Site
http://dx.doi.org/10.1002/cyto.b.21268DOI Listing
January 2016

Acute Myeloid Leukemia Response Measures Other Than Complete Remission.

J Clin Oncol 2015 Nov 17;33(31):3675-6. Epub 2015 Aug 17.

US Food and Drug Administration, Silver Spring, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.0864DOI Listing
November 2015

Librarian co-authors correlated with higher quality reported search strategies in general internal medicine systematic reviews.

J Clin Epidemiol 2015 Jun 7;68(6):617-26. Epub 2015 Feb 7.

Mayo Clinic Libraries, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08954356150005
Publisher Site
http://dx.doi.org/10.1016/j.jclinepi.2014.11.025DOI Listing
June 2015

FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma.

Clin Cancer Res 2015 Jun 23;21(12):2666-70. Epub 2015 Mar 23.

Office of Hematology and Oncology Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-3119DOI Listing
June 2015

FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease.

Clin Cancer Res 2015 Mar 19;21(5):950-4. Epub 2015 Jan 19.

Office of Hematology and Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1678DOI Listing
March 2015

Misrepresentation in multidisciplinary pain medicine fellowship applications to a single academic program.

Pain Med 2015 Feb 16;16(2):274-9. Epub 2013 Dec 16.

Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pme.12322DOI Listing
February 2015

The effects of stretching on performance.

Curr Sports Med Rep 2014 May-Jun;13(3):179-85

1Sports Health, Department of Orthopaedic Surgery, Cleveland Clinic Florida, West Palm Beach, FL; 2CORA Rehabilitation Services, Palm Beach Gardens, FL; 3Sports Medicine Center, Mayo Clinic, Rochester, MN; and 4Plummer Library, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1249/JSR.0000000000000052DOI Listing
February 2015

Transient ischemic attacks: predictability of future ischemic stroke or transient ischemic attack events.

Ther Clin Risk Manag 2014 8;10:27-35. Epub 2014 Jan 8.

Department of Neurology, The University of Kansas Medical Center, Kansas City, KS, USA.

View Article

Download full-text PDF

Source
http://www.dovepress.com/transient-ischemic-attacks-predicta
Publisher Site
http://dx.doi.org/10.2147/TCRM.S54810DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891764PMC
June 2014

Iron supplementation benefits physical performance in women of reproductive age: a systematic review and meta-analysis.

J Nutr 2014 Jun 9;144(6):906-14. Epub 2014 Apr 9.

The Micronutrient Initiative, Ottawa, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3945/jn.113.189589DOI Listing
June 2014

U.S. Food and Drug Administration approval summary: omacetaxine mepesuccinate as treatment for chronic myeloid leukemia.

Oncologist 2014 Jan 5;19(1):94-9. Epub 2013 Dec 5.

Office of Hematology and Oncology Products, Office of New Drugs, Office of Biostatistics, Office of Pharmaceutical Science, and Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2013-0077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903068PMC
January 2014

U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myeloma.

Clin Cancer Res 2013 Sep 17;19(17):4559-63. Epub 2013 Jun 17.

Office of Hematology and Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20993, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0755DOI Listing
September 2013

Gemtuzumab ozogamicin.

J Clin Oncol 2013 May 25;31(13):1699-700. Epub 2013 Mar 25.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.48.1887DOI Listing
May 2013

Exploratory factor analysis and psychometric evaluation of the teacher reporting attitude scale for child sexual abuse.

J Child Sex Abus 2012 ;21(5):489-506

Queensland University of Technology, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10538712.2012.689423DOI Listing
February 2013

Cryobiology of coral fragments.

Cryobiology 2013 Feb 7;66(1):17-23. Epub 2012 Nov 7.

Smithsonian Conservation Biology Institute, Department of Reproductive Sciences, Smithsonian National Zoological Park, Washington, DC 20008, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cryobiol.2012.10.003DOI Listing
February 2013

Converting an intranet site to the cloud: using CampusGuides to refresh a library portal.

Med Ref Serv Q 2012 ;31(3):245-57

Mayo Clinic Libraries, Mayo Clinic Health System, La Crosse, Wisconsin 54601, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/02763869.2012.698156DOI Listing
January 2013

U.S. Food and Drug Administration approval: ruxolitinib for the treatment of patients with intermediate and high-risk myelofibrosis.

Clin Cancer Res 2012 Jun 27;18(12):3212-7. Epub 2012 Apr 27.

Office of Hematology and Oncology Drug Products, Study Endpoints and Label Development, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland 20993, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-0653DOI Listing
June 2012

Teaching Web 2.0 beyond the library: adventures in social media, the class.

Med Ref Serv Q 2011 ;30(3):233-44

Mayo Clinic Libraries, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/02763869.2011.590413DOI Listing
January 2012

Accelerated approval of oncology products: the food and drug administration experience.

J Natl Cancer Inst 2011 Apr 21;103(8):636-44. Epub 2011 Mar 21.

Division of Drug Oncology Products, Office of Oncology Drug Products, 10903 New Hampshire Ave, Bldg 22, Rm 2117, Silver Spring, MD 20993, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djr062DOI Listing
April 2011

FDA approval summary: temsirolimus as treatment for advanced renal cell carcinoma.

Oncologist 2010 23;15(4):428-35. Epub 2010 Mar 23.

Division of Drug Oncology Products, Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20993-0002, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2009-0178DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227966PMC
September 2010

Towards beneficence for young children in research: challenges for bioethics committees.

Authors:
Ann Farrell

Med Law 2010 Sep;29(3):389-402

Centre for Learning Innovation, Queensland University of Technology (QUT).

View Article

Download full-text PDF

Source
September 2010

The role of the U.S. Food and Drug Administration review process: clinical trial endpoints in oncology.

Oncologist 2010 ;15 Suppl 1:13-8

U.S. Food and Drug Administration, Silver Spring, Maryland 20993, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2010-S1-13DOI Listing
July 2010

Teachers' attitudes toward reporting child sexual abuse: problems with existing research leading to new scale development.

J Child Sex Abus 2010 May;19(3):310-36

School of Early Childhood, Queensland University of Technology, Victoria Park Road, Kelvin Grove, Queensland 4059, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10538711003781392DOI Listing
May 2010

The NOURISH randomised control trial: positive feeding practices and food preferences in early childhood - a primary prevention program for childhood obesity.

BMC Public Health 2009 Oct 14;9:387. Epub 2009 Oct 14.

School of Public Health, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2458-9-387DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770488PMC
October 2009

Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.

Oncologist 2009 Feb 4;14(2):174-80. Epub 2009 Feb 4.

Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993-0002, USA.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2008-0255DOI Listing
February 2009

Sorafenib for the treatment of unresectable hepatocellular carcinoma.

Oncologist 2009 Jan 14;14(1):95-100. Epub 2009 Jan 14.

Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993-0004, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2008-0185DOI Listing
January 2009

Expediting the availability of drugs for US patients with cancer.

Nat Clin Pract Urol 2008 Dec;5(12):654-6

Division of Drug Oncology Products, US Food and Drug Administration, Rockville, MD 20847, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncpuro1255DOI Listing
December 2008

Lenalidomide in combination with dexamethasone for the treatment of multiple myeloma after one prior therapy.

Oncologist 2008 Oct 15;13(10):1120-7. Epub 2008 Oct 15.

Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland 20993-0002, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2008-0077DOI Listing
October 2008

Case, teacher and school characteristics influencing teachers' detection and reporting of child physical abuse and neglect: results from an Australian survey.

Child Abuse Negl 2008 Oct 4;32(10):983-93. Epub 2008 Nov 4.

School of Early Childhood, Queensland University of Technology, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chiabu.2008.03.002DOI Listing
October 2008

Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.

J Clin Oncol 2008 Mar 28;26(8):1371-8. Epub 2008 Jan 28.

University of Chicago, Pritzker School of Medicine, 5841 South Maryland Ave, MC 2115, Chicago, IL 60637-1463, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.13.5335DOI Listing
March 2008

Liposomal doxorubicin in combination with bortezomib for relapsed or refractory multiple myeloma.

Oncology (Williston Park) 2007 Nov;21(12):1503-8; discussion 1511, 1513, 1516 passim

Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration Silver Spring, Maryland 20993-0004, USA.

View Article

Download full-text PDF

Source
November 2007

Bortezomib for the treatment of mantle cell lymphoma.

Clin Cancer Res 2007 Sep;13(18 Pt 1):5291-4

Division of Drug Oncology Products, Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20993-0002, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-07-0871DOI Listing
September 2007

A strategic framework for novel drug development in multiple myeloma.

Br J Haematol 2007 Jul;138(2):153-9

Department of Medicine, Harvard Medical School, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1365-2141.2007.06641.x
Publisher Site
http://dx.doi.org/10.1111/j.1365-2141.2007.06641.xDOI Listing
July 2007